Pilatus Biosciences Unveils Groundbreaking Data on PLT012 at SITC 2025 Annual Meeting At SITC 2025, Pilatus Biosciences reveals impressive findings on its lead candidate PLT012, showcasing its dual mechanism to combat solid tumors.

Pilatus Biosciences Unveils Groundbreaking Data on PLT012 at SITC 2025 Annual Meeting #Switzerland #Pilatus_Biosciences #PLT012 #Epalinges #SITC_2025

Kanser dirençli tümörlere karşı yeni antikor keşfedildi

Haberin tamamını oku ➡️ tinyurl.com/ypt8wnre

__________
#kanser #cancer #immünoterapi #plt012 #cd36 #antikor #karaciğerkanseri #tümör #araştırma #research #science #health #bilim #sağlık #yaşam #nouvart

Pilatus Biosciences Set to Unveil Groundbreaking Research on PLT012 at AACR 2025 Pilatus Biosciences is preparing to showcase pivotal research regarding its leading candidate PLT012 at the AACR 2025 Annual Meeting. This research aims to address immune-cold tumors.

Pilatus Biosciences Set to Unveil Groundbreaking Research on PLT012 at AACR 2025 #United_States #Cancer_Research #Dover #Pilatus_Biosciences #PLT012

Pilatus Biosciences Achieves FDA Orphan Drug Status for Innovative Cancer Therapy Pilatus Biosciences Inc. celebrates receiving FDA Orphan Drug Designation for PLT012, a promising treatment for liver cancer.

Pilatus Biosciences Achieves FDA Orphan Drug Status for Innovative Cancer Therapy #United_States #liver_cancer #Dover #Pilatus_Biosciences #PLT012